biotech

Prime Medicine (PRME) IPO deck Members Public

Prime Medicine is a biotechnology company founded to deliver on the promise of Prime Editing, a versatile gene editing technology that can truly "search and replace" to restore normal genetic function and address the fundamental causes of disease.

Debarshi Ghosh
biotech

GlobeImmune offers little promise for IPO investors. Members Public

Kris Tuttle
Healthcare